Arteris CEO entity sells shares under 10b5-1 plan

Arteris, Inc. reported insider share sales by an entity managed by its President and CEO, Charles K. Janac.

Rhea-AI Filing Summary

Arteris, Inc. reported insider share sales by an entity managed by its President and CEO, Charles K. Janac. Bayview Legacy, LLC, over which he has voting and dispositive power, sold 47,244 shares of common stock on February 9, 2026 at a weighted average price of $15.2053 per share and 2,756 shares on February 10, 2026 at a weighted average price of $15.0322 per share. These sales were made under a Rule 10b5-1 trading plan adopted on March 5, 2025. After these transactions, Bayview Legacy, LLC held 9,349,071 shares indirectly for Janac. He also held 139,487 shares directly and 56,252 shares indirectly through the Charles and Lydia Janac Trust, where he serves as trustee.

Insider Trade Summary

Net Seller: 50,000 shares

Net Sell 4 txns

Insider JANAC K CHARLES

Role President and CEO

Sold 50,000 shs ($760K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,756	$15.0322	$41K
Sale	Common Stock	47,244	$15.2053	$718K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 9,349,071 shares (Indirect, Bayview Legacy, LLC); Common Stock — 139,487 shares (Direct); Common Stock — 56,252 shares (Indirect, Charles and Lydia Janac Trust)

Footnotes (5)

1. F1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 5, 2025.
2. F2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.51 to $15.46 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. F3. The Reporting Person is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Bayview Legacy, LLC.
4. F4. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.85 to $15.22 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. F5. The shares are held by Charles and Lydia Janac Trust, for which the Reporting Person serves as trustee.

FAQ

What insider transactions were reported for Arteris, Inc. (AIP)?

The filing reports indirect open‑market sales of Arteris (AIP) common stock by Bayview Legacy, LLC, an entity managed by President and CEO Charles K. Janac. It sold 47,244 shares on February 9, 2026 and 2,756 shares on February 10, 2026 at weighted average prices.

Who executed the Arteris (AIP) share sales disclosed in this Form 4?

The sales were executed by Bayview Legacy, LLC, which is managed by Arteris (AIP) President and CEO Charles K. Janac. He is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC, making these indirect transactions associated with him.

Were the Arteris (AIP) insider sales under a 10b5-1 trading plan?

Yes. The filing states the transactions were made under a Rule 10b5‑1 trading plan adopted by the reporting person on March 5, 2025. Such plans pre‑schedule trades, helping demonstrate that the sales were planned rather than reactive to short‑term market or company events.

At what prices were the Arteris (AIP) shares sold in these insider transactions?

The February 9, 2026 sale had a weighted average price of $15.2053 per Arteris (AIP) share, with trades ranging from $14.51 to $15.46. The February 10, 2026 sale had a weighted average price of $15.0322, with individual trades between $14.85 and $15.22 per share.

How many Arteris (AIP) shares did Bayview Legacy, LLC hold after the reported sales?

After the reported transactions, Bayview Legacy, LLC beneficially owned 9,349,071 Arteris (AIP) common shares indirectly for Charles K. Janac. This figure reflects holdings following the February 10, 2026 sale, as disclosed in the Form 4’s post‑transaction ownership column for the entity.

What other Arteris (AIP) share holdings does Charles K. Janac report?

In addition to indirect holdings via Bayview Legacy, LLC, Charles K. Janac reports 139,487 Arteris (AIP) common shares held directly. He also reports 56,252 shares held indirectly through the Charles and Lydia Janac Trust, for which he serves as trustee, indicating additional beneficial ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/11/2026 - 07:01 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

JANAC K CHARLES

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL CA 95008

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/09/2026		S(1)		47,244	D	$15.2053(2)	9,351,827	I	Bayview Legacy, LLC(3)
Common Stock	02/10/2026		S(1)		2,756	D	$15.0322(4)	9,349,071	I	Bayview Legacy, LLC(3)
Common Stock								139,487	D
Common Stock								56,252	I	Charles and Lydia Janac Trust(5)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 5, 2025.

2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.51 to $15.46 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The Reporting Person is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Bayview Legacy, LLC.

4. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.85 to $15.22 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

5. The shares are held by Charles and Lydia Janac Trust, for which the Reporting Person serves as trustee.

Remarks:

	/s/ Paul Alpern, as Attorney-in-Fact for JANAC K CHARLES	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.